Published in Arch Virol on January 01, 1991
Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J Virol (1995) 3.67
Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions. J Virol (1996) 2.75
The NS1 protein of tick-borne encephalitis virus forms multimeric species upon secretion from the host cell. J Gen Virol (1994) 1.24
Inactivated vaccine against tick-borne encephalitis (TBE) derived from heteroploid continuous monkey cell line. Vaccine (1989) 1.06
Detection of hepatitis C virus core protein circulating within different virus particle populations. J Med Virol (1998) 1.00
[Chromatin activation and various problems of genetic activity regulation in eukaryotic cells]. Mol Biol (Mosk) (1985) 0.92
Centrosome injury in cells infected with human cytomegalovirus. J Struct Biol (1997) 0.91
Immunological basis for protection in a murine model of tick-borne encephalitis by a recombinant adenovirus carrying the gene encoding the NS1 non-structural protein. J Gen Virol (1998) 0.91
Determination of the proteins and capsids of herpes simplex virus in human spermatozoa. Dokl Biol Sci (2003) 0.88
Detection of herpes simplex virus genomic DNA in spermatozoa of patients with fertility disorders by in situ hybridization. Dokl Biol Sci (2007) 0.87
[Protective activity of a bacterial plasmid, bearing the gene for the tick-borne encephalitis virus NS1 nonstructural protein]. Vopr Virusol (2001) 0.86
In vivo study of engineered G-domain mutants of Escherichia coli translation initiation factor IF2. Mol Microbiol (1994) 0.85
Peculiarities of cytochemical properties of cancer cells as revealed by study of deoxyribonucleoprotein susceptibility to Feulgen hydrolysis. J Histochem Cytochem (1977) 0.85
A monoclonal antibody that recognizes the predicted tick-borne encephalitis virus E protein fusion sequence blocks fusion. Arch Virol (1999) 0.84
[Herpes simplex virus and cytomegalovirus in male ejaculate: herpes simplex virus is more frequently encountered in idiopathic infertility and correlates with the reduction in sperm parameters]. Vopr Virusol (2010) 0.84
[Effect of cytomegalovirus on cell cycle progression and formation of pathological mitoses in cultured human diploid fibroblasts]. Ontogenez (2001) 0.81
A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model. Virus Res (2005) 0.81
Vaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice. Immunol Lett (2003) 0.81
[Connection between severity of the course of tick-borne encephalitis with the concentration of interleukin-2 and interleukin-6 in blood]. Ter Arkh (2002) 0.81
Characterization of monoclonal antibodies and epitope mapping of the NS4 protein of hepatitis C virus. Immunol Lett (2002) 0.81
[Irreversible changes in the ultrastructure of kinetochores in mitosis, caused by human cytomegalovirus]. Dokl Akad Nauk (1999) 0.80
[Immunochemical properties and specificity of monoclonal antibodies against N- and C-terminal sites of the recombinant protein of the nucleocapsid of hepatitis C virus (HCcAg)]. Vopr Virusol (1997) 0.80
[Herpetic infection of spermatozoa in failure of reproductive technologies and spontaneous abortion]. Urologiia (2007) 0.80
Serum levels of interleukin 6 in recently hospitalized tick-borne encephalitis patients correlate with age, but not with disease outcome. Clin Exp Immunol (2008) 0.80
[Asymptomatic genital herpes infection and infertility in males]. Urologiia (2007) 0.80
Mechanism for dendritic cell dysfunction in retroviral infection of mice. Clin Immunol Immunopathol (1996) 0.80
[Effect of herpes simplex virus on spermatogenesis]. Urologiia (2012) 0.80
[Preparation of monoclonal antibodies to super early human cytomegalovirus proteins and their use for detecting infected cells]. Vopr Virusol (1996) 0.79
Combined prime-boost vaccination against tick-borne encephalitis (TBE) using a recombinant vaccinia virus and a bacterial plasmid both expressing TBE virus non-structural NS1 protein. BMC Microbiol (2005) 0.79
Ex vivo production of interferon-gamma, tumor necrosis factor-alpha, and interleukin-6 by mouse macrophages during infection with M. bovis and M. tuberculosis H37Rv. Bull Exp Biol Med (2007) 0.79
[Changes of humoral and cellular immunity in chronic hepatitis C patients of different staging]. Vopr Virusol (2003) 0.78
A vesicular stomatitis pseudovirus expressing the surface glycoproteins of influenza A virus. Arch Virol (2014) 0.78
[Monoclonal antibodies in the diagnosis of infections caused by the herpes simplex virus]. Zh Mikrobiol Epidemiol Immunobiol (2000) 0.78
[Immunostimulating effect of water-soluble fullerene derivatives--perspective adjuvants for a new generation of vaccine]. Dokl Akad Nauk (1999) 0.78
Tick-borne encephalitis virus interaction with the target cells. Arch Virol (1992) 0.78
[DNA content in dysplasias and early invasive forms of cervical cancer]. Vopr Onkol (1977) 0.77
The influence of 0.35 M sodium chloride treatment on physico-chemical properties of liver chromatin in partially hepatectomized guinea pigs. Exp Cell Res (1974) 0.77
[DNA immunization with a plasmid containing gene of hepatitis C virus protein 5A (NS5A) induces the effective cellular immune response]. Mol Biol (Mosk) (2010) 0.77
[A quantitative change in topoisomerase type I in the cell cycle of Chinese hamster fibroblasts]. Dokl Akad Nauk SSSR (1989) 0.77
[Protective effect of a new antiviral preparation of phosprenyl in experimental tick-borne encephalitis]. Vopr Virusol (2000) 0.77
Characteristics of inactivated hepatitis A vaccine prepared from virus propagated in heteroploid continuous monkey cell line. Vaccine (1990) 0.77
Innate immunity including epithelial and nonspecific host factors: workshop 1B. Adv Dent Res (2011) 0.77
Karyological approach to the identification of true cell lines susceptible to the human immunodeficiency virus (HIV). Biomed Sci (1991) 0.77
[Experimental study of the phenomenon of antibody dependent tick-borne encephalitis virus infectivity enhancement in vitro]. Zh Mikrobiol Epidemiol Immunobiol (2009) 0.77
[Different regulation of mitochondrial apoptosis and Bcl-2 gene expression in quescent and proliferative human fibroblasts infected with cytomegalovirus]. Tsitologiia (2010) 0.76
Localization of HTLV-1 and HIV-1 proviral sequences in chromosomes of persistently infected cells. Chromosome Res (1999) 0.76
[Epitope mapping of antigenic determinants of hepatitis C virus proteins by phage display]. Mol Biol (Mosk) (2006) 0.76
Cytogenetic analysis of human hepatocarcinoma cell line PLC-PRF-5 and its mutant clones with different degrees of cell differentiation. Cancer Genet Cytogenet (1993) 0.76
DNA-topoisomerases and regulation of cell proliferation. Adv Enzyme Regul (1986) 0.76
[DNA vaccine encoding alpha-fetoprotein with fused ornithine decarboxylase degradation signal significantly suppresses hepatocellular carcinoma growth in mice]. Mol Biol (Mosk) (2012) 0.75
Immunogenicity trial of inactivated hepatitis A virus vaccine in human volunteers. Vaccine (1991) 0.75
Development of monoclonal antibodies to highly pathogenic avian influenza H5N1 virus and their application to diagnostics, prophylaxis, and therapy. Acta Virol (2011) 0.75
Reevaluation of the proteins in rabies virus particles. J Virol (1979) 0.75
[The effect of viral infections on the cytokine profile in pregnant women with obstetric complications and immunotherapy with human alpha2b interferon]. Vopr Virusol (2013) 0.75
[Monoclonal antibodies to highly pathogenic avian influenza A(H5N1) strain isolated in the Russian Federation: development and properties]. Vopr Virusol (2008) 0.75
[The development and testing of test systems for the determination of herpes simplex virus and cytomegalovirus antigens by lanthanide immunofluorescence analysis]. Zh Mikrobiol Epidemiol Immunobiol (2000) 0.75
[Changes in the gene expression of the hepatitis B virus in PLC-PRF-5 cells of human hepatocarcinoma during their acquisition of drug resistance]. Vopr Virusol (1993) 0.75
[Differentiation of tick-borne encephalitis viruses using monoclonal antibodies]. Mol Gen Mikrobiol Virusol (1986) 0.75
[Comparison of adjuvant activities of glucosaminyl-muramyl dipeptide and of the gene coding for granulocyte-macrophage colony-stimulating factor in DNA immunization against herpes simplex virus]. Mol Biol (Mosk) (2005) 0.75
[Detection of direct markers of cytomegalovirus. Research of the spectrum and avidity of antiviral antibodies in infants and preschool children]. Vopr Virusol (2005) 0.75
[Human hybridoma neutralizing antibodies to the herpes simplex virus]. Vopr Virusol (1993) 0.75
[Carboxy mimetic derivatives of nucleic acid polymeric backbones inhibiting human cytomegalovirus. 1. In vitro microbicidal effect]. Antibiot Khimioter (2007) 0.75
[Regulation of human fibrolastic 2',5'-oligoadenylate synthetase gene activity in cytomegalovirus infected fibroblast cells]. Vopr Virusol (2007) 0.75
[The immunoenzyme test system for detection of HIV-1 antigens based on using immune polyclonal anti-HIV serum and monoclonal antibodies against gene GAG HIV-1 proteins]. Vestn Ross Akad Med Nauk (1992) 0.75
[The protective activity of preparations made from the tick-borne encephalitis virus grown using different cell cultures]. Zh Mikrobiol Epidemiol Immunobiol (1992) 0.75
[In vitro antiviral activity of fullerene amino acid derivatives in cytomegalovirus infection]. Antibiot Khimioter (2004) 0.75
Preparation and characterization of hybridomas secreting monoclonal antibodies to tick-borne encephalitis virus. Acta Virol (1986) 0.75
The changes in the properties of chromatin from activated and non-activated lymphocytes at different stages of maturation under the action of salt solutions of different concentration. Cell Differ (1980) 0.75
[Analysis of the stability of some properties of tick-borne encephalitis virus (strain 205) upon passaging in mice]. Vopr Virusol (1996) 0.75
[Comparative evaluation of methods for increasing the sensitivity of radioautographic analysis by using scintillation mixtures]. Ontogenez (1980) 0.75
[Immunocytophotometric and cytogenetic analyses of T-lymphoblastoid cell lines in experimental HIV Infection]. Vopr Virusol (1994) 0.75
[Antiviral activity of polycarboxylic substances modified by cage hydrocarbon and sulfoacid pharmacophors against cytomegalovirus infection in vitro]. Antibiot Khimioter (2008) 0.75
[Localization of the CD4 receptor gene in the chromosomes of clone cells of the monocytoid line U-937 characterized by different sensitivities to HIV]. Tsitologiia (1994) 0.75
[Hybridomas producing monoclonal antibodies to influenza viruses]. Vopr Virusol (1985) 0.75
[Karyological analysis of hybridoma lines producing monoclonal antibodies to viral antigens]. Tsitol Genet (1986) 0.75
Changes in expression of surface and core antigens of hepatitis B virus in different mutant clones of hepatoma PLC-PRF-5 cells. Virus Res (1993) 0.75
[The detection of the herpes simplex virus 1 and 2 antigens in clinical specimens by using monoclonal antibodies]. Zh Mikrobiol Epidemiol Immunobiol (2000) 0.75
[Properties of monoclonal antibodies interacting with determinants of hepatitis B virus surface antigen]. Mol Gen Mikrobiol Virusol (1986) 0.75
[Serological characteristics of KAMA-51 monoclonal antibodies to the tick-borne encephalitis virus]. Vopr Virusol (1986) 0.75
[Preparation and use of monoclonal antibodies to the Inkoo virus (Bunyaviridae, Bunyavirus) for differentiating between California serogroup viruses]. Vopr Virusol (1998) 0.75
[CMV-induced cell death and fas gene expression in resting and proliferating human fibroblasts]. Zh Mikrobiol Epidemiol Immunobiol (2008) 0.75
Chromatin activation in peritoneal exudate leukocytes after fusion with L cell cytoplasts. Cytobiologie (1978) 0.75
[Generation and characteristics of hybridomas producing monoclonal antibodies to the surface antigen of hepatitis B virus]. Vopr Virusol (1987) 0.75
[The immunoenzyme detection of the HIV-1 antigen by using monoclonal antibodies to protein p24]. Vopr Virusol (1993) 0.75
[Comparative analysis of hepatitis C virus core protein in the plasma and serum samples from HCV-infected blood donors and patients with hepatitis C]. Vopr Virusol (2007) 0.75
[The use of DNA hybridization in situ for identifying chromosomal rearrangements in the karyotyping of cell lines]. Tsitologiia (1992) 0.75
Two kinds of monoclonal antibodies to tick-borne encephalitis virus. Acta Virol (1986) 0.75
[Rapid entrance into the S-period by the nuclei of lymph node lymphocytes in heterokaryons and reconstructed cells]. Dokl Akad Nauk SSSR (1979) 0.75
[Increased sensitivity of tumor cell deoxyribonucleoproteins to acid hydrolysis in the Feulgen reaction]. Dokl Akad Nauk SSSR (1976) 0.75
[Quantitative laboratory methods for the diagnosis of cytomegalovirus infection in premature infants]. Vopr Virusol (2005) 0.75
[The HTHIV27 highly productive continuous cell line and its use for solving the fundamental and applied problems of HIV infection]. Zh Mikrobiol Epidemiol Immunobiol (1999) 0.75
[Reduced malignancy of hybrids of tumor cells fused with lymph node lymphocytes of syngeneic rats]. Vopr Onkol (1987) 0.75
[Detection of the markers of herpes simplex virus and cytomegalovirus in newborns and infants]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.75
[Hepatitis C virus proteins in the liver cells in acute hepatitis C: their association with liver damage and with the outcome of the disease]. Vopr Virusol (2005) 0.75
[Differing degrees of reactivation of peritoneal cell nuclei in heterokaryons with resting, proliferation-stimulated and constantly proliferating cells]. Dokl Akad Nauk SSSR (1981) 0.75